Bavarian Nordic's vaccine has potential to last longer than competition, says CEO
![Photo: Philip Davali/Ekstra Bladet, Philip Davali](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13529942.ece/ALTERNATES/schema-16_9/doc7ipvkwsvsxt14r7ifhr.jpg)
Danish biotech firm Bavarian Nordic’s CEO, Paul Chaplin, says that having a vaccine that provides longer protection against Covid-19 would be an advantage, as reported by Danish business daily Børsen.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Bavarian aims for universal Covid-19 booster
For subscribers